CTLA4 and neoplasm: Accordingly, we harvested subcutaneous tumours from mice treated with anti-PD-1, anti-CTLA-4, both anti-PD-1 and anti-CTLA-4 or relevant isotype controls, and we assessed immune infiltrates by flow cytometry (electronic supplementary material, figure S1).